Natasha van Eijkelenburg Selected Research

Natasha van Eijkelenburg Research Topics

2	Neuroblastoma 01/2024 - 01/2020
2	Neoplasms (Cancer) 11/2021 - 12/2020
1	Osteosarcoma (Osteogenic Sarcoma) 11/2023
1	COVID-19 12/2020
1	Fever (Fevers) 01/2020
1	Pain (Aches) 01/2020
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2020
1	Disease Progression 01/2020
1	Sepsis (Septicemia) 01/2020
1	Catheter-Related Infections 01/2020

2	Temozolomide (Temodar)FDA LinkGeneric 01/2024 - 11/2021
2	Topotecan (Hycamtin)FDA LinkGeneric 01/2024 - 11/2021
1	Bevacizumab (Avastin)FDA Link 01/2024
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2024
1	Angiogenesis InhibitorsIBA 01/2024
1	Phosphotransferases (Kinase)IBA 11/2023
1	ribociclibIBA 11/2021
1	Everolimus FDA Link 11/2021
1	dinutuximabIBA 01/2020
1	Interleukin-2 (IL2)IBA 01/2020
1	Isotretinoin (Accutane)FDA LinkGeneric 01/2020

2	Therapeutics 11/2023 - 01/2020
1	Drug Therapy (Chemotherapy) 01/2024
1	Investigational Therapies (Experimental Therapy) 12/2020
1	Catheters 01/2020
1	Immunotherapy 01/2020